Shreeyashi Ojha

Reporter, BioProcess Insider

Journalist covering the manufacturing and processing sectors for biopharmaceuticals globally.  

Originally from India, I am a Londoner at heart. I have recently graduated from Goldsmiths, University of London.  

Feel free to reach out to me at: [email protected].

Latest from Shreeyashi Ojha

thumbnail
Facilities & Capacity
Lonza doubles bioconjugation capacity at Swiss facilityLonza doubles bioconjugation capacity at Swiss facility
byShreeyashi Ojha
Nov 16, 2024
2 Min Read
thumbnail
Facilities & Capacity
Cytiva strengthens APAC presence with Korea plantCytiva strengthens APAC presence with Korea plant
byShreeyashi Ojha
Nov 16, 2024
2 Min Read

All from Shreeyashi Ojha

Therapeutic Class
Repligen credits 10% revenue surge to new modalities and M&As
Repligen credits 10% revenue surge to new modalities and M&As
Nov 15, 2024
|
3 Min Read
byShreeyashi Ojha
Deal-Making
Novo taps Ascendis in $285m GLP-1 deal
Novo taps Ascendis in $285m GLP-1 deal
Nov 13, 2024
|
1 Min Read
byShreeyashi Ojha
Facilities & Capacity
AmplifyBio bolsters Ohio plant with $50m backing from Vitrian
AmplifyBio bolsters Ohio plant with $50m backing from Vitrian
Nov 12, 2024
|
1 Min Read
byShreeyashi Ojha
Therapeutic Class
Post-pandemic dip: Panelists discuss CGT challenges
Post-pandemic dip: Panelists discuss CGT challenges
Nov 8, 2024
|
3 Min Read
byShreeyashi Ojha
Facilities & Capacity
Thermo Fisher expands India footprint with bioprocess design center
Thermo Fisher expands India footprint with bioprocess design center
Nov 7, 2024
|
3 Min Read
byShreeyashi Ojha
Facilities & Capacity
Sterling doubles ADC capacity at UK facility
Sterling doubles ADC capacity at UK facility
Nov 7, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Ardena bolsters bioanalytical capacity with Netherlands lab construction
Ardena bolsters bioanalytical capacity with Netherlands lab construction
Oct 30, 2024
|
2 Min Read
byShreeyashi Ojha
Deal-Making
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Pluri, BIRAD bring tumor-fighting MAIT cells to commercial viability
Oct 30, 2024
|
3 Min Read
byShreeyashi Ojha
Facilities & Capacity
MilliporeSigma bolsters ADC business with $76m US expansion
MilliporeSigma bolsters ADC business with $76m US expansion
Oct 29, 2024
|
1 Min Read
byShreeyashi Ojha
Facilities & Capacity
Celltechna opens $54m gene therapy center in Lithuania
Celltechna opens $54m gene therapy center in Lithuania
Oct 29, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Rentschler bolsters production with 3,400 square-meter expansion
Rentschler bolsters production with 3,400 square-meter expansion
Oct 25, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Ins & Outs: Forge, Veranova, Cellipont announce C-suite rejigs
Ins & Outs: Forge, Veranova, Cellipont announce C-suite rejigs
Oct 24, 2024
|
3 Min Read
byShreeyashi Ojha
Therapeutic Class
Investors prioritize efficacy in the CGT biz, experts say
Investors prioritize efficacy in the CGT biz, experts say
Oct 23, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
CDMO AGC places CO plant on ice amid turbulent CGT economy
CDMO AGC places CO plant on ice amid turbulent CGT economy
Oct 17, 2024
|
2 Min Read
byShreeyashi Ojha
Therapeutic Class
USPs and efficacy driving CGT competitiveness
USPs and efficacy driving CGT competitiveness
Oct 16, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Amgen to divest ex-Horizon aseptic plant by 2026
Amgen to divest ex-Horizon aseptic plant by 2026
Oct 15, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Now open: Millipore’s Maryland facility slashes virus testing time
Now open: Millipore’s Maryland facility slashes virus testing time
Oct 9, 2024
|
2 Min Read
byShreeyashi Ojha
Deal-Making
Recipharm and Exela collaborate to boost US sterile injectable production
Recipharm and Exela collaborate to boost US sterile injectable production
Oct 9, 2024
|
3 Min Read
byShreeyashi Ojha
Deal-Making
Xcellbio and AmplifyBio partner to advance cell-therapy development
Xcellbio and AmplifyBio partner to advance cell-therapy development
Oct 8, 2024
|
4 Min Read
byShreeyashi Ojha
Facilities & Capacity
Ferring bolsters Adstiladrin production with Finland expansion
Ferring bolsters Adstiladrin production with Finland expansion
Oct 7, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Expansion Special: J&J, Ascend, and Aspen ramp up global biomanufacturing capacity
Expansion Special: J&J, Ascend, and Aspen ramp up global biomanufacturing capacity
Oct 4, 2024
|
3 Min Read
byShreeyashi Ojha
Facilities & Capacity
Ins & Outs: Leadership shuffles at CDMOs
Ins & Outs: Leadership shuffles at CDMOs
Oct 4, 2024
|
3 Min Read
byShreeyashi Ojha
Deal-Making
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Legend Bio and Multiply Labs partner to improve CAR-T manufacturing
Oct 2, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
ABT scales production capacity with Spain facility expansion
ABT scales production capacity with Spain facility expansion
Oct 1, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
CompleCure taps AGC for AMDC-based cancer-therapy development
CompleCure taps AGC for AMDC-based cancer-therapy development
Sep 30, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
PCI forks out $365m, expands US and Ireland operations
PCI forks out $365m, expands US and Ireland operations
Sep 26, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Verdot ups bioprocessing capacity by 150% with French expansion
Verdot ups bioprocessing capacity by 150% with French expansion
Sep 26, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
Quell, eXmoor partner to advance autologous CAR-Treg therapies
Quell, eXmoor partner to advance autologous CAR-Treg therapies
Sep 26, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Swiss CDMO ten23 health bolsters manufacturing with facility expansion
Swiss CDMO ten23 health bolsters manufacturing with facility expansion
Sep 25, 2024
|
2 Min Read
byShreeyashi Ojha
Deal-Making
Charles River and Ori Biotech collaborate on CAR-T production
Charles River and Ori Biotech collaborate on CAR-T production
Sep 20, 2024
|
3 Min Read
byShreeyashi Ojha
Facilities & Capacity
Thermo Fisher expands Swedish bioanalytical laboratory
Thermo Fisher expands Swedish bioanalytical laboratory
Sep 20, 2024
|
1 Min Read
byShreeyashi Ojha
Deal-Making
MinervaX taps Wacker for clinical and commercial GBS vaccine supply
MinervaX taps Wacker for clinical and commercial GBS vaccine supply
Sep 19, 2024
|
2 Min Read
byShreeyashi Ojha
Facilities & Capacity
Ins & Outs: C-suite rejigs at Regenxbio, Kyverna and Mirador
Ins & Outs: C-suite rejigs at Regenxbio, Kyverna and Mirador
Sep 18, 2024
|
3 Min Read
byShreeyashi Ojha

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024